Banexi Ventures Partners  
Search :  
Home page | Contact us | Site map      

» About us
» Our expertise
» Team
» Portfolio
» News

» Contact us
» Home page

  Banexi Ventures Partners

Banexi Ventures Partners is a French independent managing company. Banexi Ventures Partners invests through Venture Capital Funds, in early stage companies with high growth potential and high technology in 3 different sectors:

  • Internet
  • Electronic
  • Medical Technologies

Banexi Ventures Partners has been operating as BVP team for 14 years:

  • 357 M€ invested since 1983
  • In 260 companies
  • 132 exits M&A (Kelkoo, Inventel,…) or IPO (Soitec, Exonhit, Aden Classified… )

Banexi Ventures Partners has paneuropean investors and some business angels who contribute with their expertise in their specific knowledge area.

Banexi Ventures Partners has a very close relationship with BNP Paribas Group due to its history (spin out).


Banexi Ventures Partners is commited to a sustainable investment policy by integrating the ESG (Environmental, Social and Governance) criteria (into their investment strategy).

Several actions have been implemented:
- A chart has been completed by Banexi Ventures Partners and signed by all the members of the team.
- Since October 2011 all new investments of BV5 FCPR complies with our ESG policy: from due diligence process to the lifetime of the investment.





VEXIM double son chiffre d’affaires au 1er trimestre 2014 à 2,1 M€
    » Read more

Native technology platform and network Adyoulike announces major UK acquisition to create European leader in native advertising
    » Read more

VEXIM / Une étude rétrospective menée sur 178 patients suivis jusqu’à 5 ans confirme les excellents résultats long terme du SpineJack® dans le traitement des fractures vertébrales par compression
    » Read more

Linkfluence acquires TrendyBuzz: a milestone in the Social Media Intelligence field
    » Read more

Criteo Acquires Tedemis, Expanding Customer Reach Across Channels
    » Read more

VEXIM reçoit le « Prix Biotech d’Avenir » Technology Fast 50 Région Sud-Ouest, par Deloitte In Extenso
    » Read more

Cession de notre participation : CSM Intruments passe en mains autrichiennes
    » Read more

VEXIM : une étude rétrospective avec un recul de plus de 5 ans sur 77 patients confirme les excellents résultats long terme du SpineJack® dans le traitement des fractures vertébrales par compression
    » Read more

Symetis announces successful, first time implantation of its ACURATE TA™ and ACURATE TF™ TAVI systems in Japan
    » Read more

Vexim : poursuite de la forte accélération des ventes au S1 2013 : +133% à 2,5 M€
    » Read more

L’Essayage des lunettes plus réaliste Fittingbox
    » Read more

Symetis’ ACURATE TA™ Confirms Superior Results
    » Read more

VEXIM ouvre sa 4ème filiale en Europe et s’implante au Royaume‐Uni
    » Read more

Banexi invested 1 milion euros in the start up Oxxius, a French Laser Manufacturer company
    » Read more

Sagem (Safran) acquires Swiss company Colibrys SA
    » Read more

Adyoulike unveils the concept of « Native Advertising » in Europe and announces raising a Series-­‐A of €1.2million with Banexi Ventures Partners.
    » Read more

VEXIM étoffe son équipe de Direction Nomination de Delphine Gricourt au poste de Directrice Marketing et Relations Investisseurs de Vexim
    » Read more

Vexim accélère son développement européen et s’implante en Espagne
    » Read more

 Discover Portfolio Videos



Site web réalisé avec Clic Premium - version 4 / © innovation Partners, tous droits réservés.